In summary, we have demonstrated some of the effects of CDK8 inhibition on CDK8, E2F1, STAT3, and Mcl-1 proteins in MDA-MB-468 triple-negative breast cancer cells. This evidence concerns the gene CDK8 and triple-negative breast carcinoma.